Anderson Diagnostics launches Tata MD Check

Trinity Mirror Chennai 24th March

Tata Medical and Diagnostics (Tata MD), the new healthcare venture from the house of Tata, announced today that it has entered into a wide-ranging clinical collaboration with Chennai-based Anderson Diagnostics & Labs (ADL), to standardize the indigenously-developed Tata MD CHECK in a bid to slow down the rate of new infections.

The collaboration with clinical experts of ADL has helped ensure that the "Made-in-India" Tata MD CHECK diagnostic kit can be scaled rapidly with ADL having already successfully conducted over 10,000 COVID tests using this new, DGCA approved ICMR guidelines, novel diagnostic solution based on Feluda CRISPR Platform. `Having tested and validated more than 10000 samples, we feel this technology is on par with the best in the world and futuristic as well.

Moreover, Tata MD CHECK's ability to perform using inexpensive lab equipment like standard thermocyclers will be a boost for small labs in tier 11/111 towns and villages to start COVID testing locally" said Dr AnandKri shnamoorthy, Managing Director, Anderson Diagnostics.

"Working with the exceptional team at Anderson Diagnostics has demonstrated the impact that a new technology-based product like Tata MD CHECK can have on strengthening our COVID testing capacity and access to testing in remote areas.Tata's clinical collaboration with Anderson Diagnostics will only drive advances in the diagnostic space of COVID-19 as the pandemic continues"said Girish Krishnainurthy, MD & CEO, Tata Medical and Diagnostics.